Malluche HH - Search Results

1

Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure.

Lomashvili KA, Monier-Faugere MC, Wang X, Malluche HH, O'Neill WC. Lomashvili KA, et al. Among authors: malluche hh. Kidney Int. 2009 Mar;75(6):617-25. doi: 10.1038/ki.2008.646. Epub 2009 Jan 7. Kidney Int. 2009. PMID: 19129793 Free PMC article.

2

Animal models for the study of bone loss after cessation of ovarian function.

Rodgers JB, Monier-Faugere MC, Malluche H. Rodgers JB, et al. Bone. 1993 May-Jun;14(3):369-77. doi: 10.1016/8756-3282(93)90166-8. Bone. 1993. PMID: 8363880 Review. No abstract available.

3

High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation.

Monier-Faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH. Monier-Faugere MC, et al. Among authors: malluche hh. J Am Soc Nephrol. 2000 Jun;11(6):1093-1099. doi: 10.1681/ASN.V1161093. J Am Soc Nephrol. 2000. PMID: 10820173

4

Use and indication of vitamin D and vitamin D analogues in patients with renal bone disease.

Malluche HH, Monier-Faugere MC, Koszewski NJ. Malluche HH, et al. Nephrol Dial Transplant. 2002;17 Suppl 10:6-9. doi: 10.1093/ndt/17.suppl_10.6. Nephrol Dial Transplant. 2002. PMID: 12386263 Review.

5

Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure.

Langub MC, Monier-Faugere MC, Wang G, Williams JP, Koszewski NJ, Malluche HH. Langub MC, et al. Among authors: malluche hh. Endocrinology. 2003 Apr;144(4):1135-8. doi: 10.1210/en.2002-221026. Endocrinology. 2003. PMID: 12639892

6

Pth 1-84, Pth fragments and bone turnover.

Malluche HH, Monier-Faugere MC. Malluche HH, et al. Am J Kidney Dis. 2003 May;41(5):1127. doi: 10.1016/s0272-6386(03)00296-8. Am J Kidney Dis. 2003. PMID: 12722056 No abstract available.

7

Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease.

Sawaya BP, Butros R, Naqvi S, Geng Z, Mawad H, Friedler R, Fanti P, Monier-Faugere MC, Malluche HH. Sawaya BP, et al. Among authors: malluche hh. Kidney Int. 2003 Aug;64(2):737-42. doi: 10.1046/j.1523-1755.2003.00129.x. Kidney Int. 2003. PMID: 12846773 Free article.

8

The importance of bone health in end-stage renal disease: out of the frying pan, into the fire?

Malluche HH, Mawad H, Monier-Faugere MC. Malluche HH, et al. Nephrol Dial Transplant. 2004 Mar;19 Suppl 1:i9-13. doi: 10.1093/ndt/gfh1002. Nephrol Dial Transplant. 2004. PMID: 15126648 Review.

9

Opposite effects of calcitriol and paricalcitol on the parathyroid hormone-(1-84)/large carboxy-terminal-parathyroid hormone fragments ratio in patients with stage 5 chronic kidney disease.

Monier-Faugere MC, Mawad H, Malluche HH. Monier-Faugere MC, et al. Among authors: malluche hh. Clin J Am Soc Nephrol. 2007 Nov;2(6):1255-60. doi: 10.2215/CJN.03461006. Epub 2007 Oct 17. Clin J Am Soc Nephrol. 2007. PMID: 17942766

10

Effects of sevelamer hydrochloride and calcium carbonate on renal osteodystrophy in hemodialysis patients.

Ferreira A, Frazão JM, Monier-Faugere MC, Gil C, Galvao J, Oliveira C, Baldaia J, Rodrigues I, Santos C, Ribeiro S, Hoenger RM, Duggal A, Malluche HH; Sevelamer Study Group. Ferreira A, et al. Among authors: malluche hh. J Am Soc Nephrol. 2008 Feb;19(2):405-12. doi: 10.1681/ASN.2006101089. Epub 2008 Jan 16. J Am Soc Nephrol. 2008. PMID: 18199805 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page